• DHL's Cool Green Cell will be used for temperature-controlled shipments of pharmaceuticals and medicines in all states of Australia by the end of the year.
    DHL's Cool Green Cell will be used for temperature-controlled shipments of pharmaceuticals and medicines in all states of Australia by the end of the year.
Close×

Global logistics company DHL has chosen Australia for the Asia-Pacific launch of a new re-usable and trackable packaging product for the safe transport of pharmaceutical and medical products requiring refrigeration in transport.

Dubbed the Cool Green Cell, the new packaging format is designed for shipments of pharmaceutical items that must be kept in controlled temperatures between +2°C and +8°C.

The packaging has been launched in NSW and Queensland, with the product planned to go live in other states by the end of 2013. DHL, part of Germany's Deutsche Post, said it also plans to launch the Cool Green Cell to other countries within the Asia Pacific region, but set no firm timetable.

The Cool Green Cell packaging is made of high quality polyurethane and includes embedded radio frequency identification (RFID) technology to enable complete tracking of deliveries through the supply chain.

“The launch of The Cool Green Cell in Australia signifies the start of a new chapter for cold chain deliveries in this country,” Saul Resnick, the vice-president for life sciences and healthcare in DHL's supply chain group, said.

“DHL has devised a temperature controlled packaging solution aimed at pharmacies, hospitals and clinicians, that is reusable, returnable and easily identifiable.

“This means our customers can reduce their supply chain costs and the time they would normally dedicate to waste management, all the while knowing they are using a solution that is environmentally friendly.”

Food & Drink Business

Snacking and pet food company, Mars Incorporated, is set to open a new $112.5 million wet pouch facility at its Wodonga pet food factory this June, initially announced in June 2023.

The a2 Milk Company has initiated a voluntary recall of three batches of its US-label a2 Platinum infant formula after cereulide was detected in the product. The recall covers approximately 16,428 tins already sold to consumers, with no reported incidents of infant illness.

Inghams Group Limited has appointed Grant Douglas as the company’s new chief financial officer, taking effect from October 2026. He takes over the role from Gary Mallett, who is stepping down on 30 September, after seven years with the company.